Evidence map›Paper›PMID 34574871›Full record

ArticleHealthcare (Basel, Switzerland)2021

Assessment of Pharmacists' Knowledge and Practices towards Prescribed Medications for Dialysis Patients at a Tertiary Hospital in Riyadh Saudi Arabia.

Lolwa Al-Abdelmuhsin, Maha Al-Ammari, Salmeen D Babelghaith, Syed Wajid, Abdulrahman Alwhaibi, Sultan M Alghadeer, Mohamed N Al Arifi, Ziyad Alrabiah

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lolwa Al-AbdelmuhsinPharmaceutical Care Services, Ministry of the National Guard-Health Affairs, Riyadh 11426, Saudi Arabia.ORCID 0000-0003-3965-0660
Maha Al-AmmariKing Abdullah International Medical Research Centre, Riyadh 11481, Saudi Arabia.
Salmeen D BabelghaithClinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Syed WajidClinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-4077-4524
Abdulrahman AlwhaibiClinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-8519-3363
Sultan M AlghadeerClinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Mohamed N Al ArifiClinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Ziyad AlrabiahClinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
King Saud University · SAKing Abdullah International Medical Research Center · SANational Guard Health Affairs · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe present study examined pharmacists' knowledge and practices towards prescribed medications for hemodialysis patients. The impact of a pharmacist's current positions and years of experience on practices and knowledge was also assessed.

methodsA cross-sectional survey was distributed to pharmacists working at King Abdul-Aziz Medical City-Central Region over a period of 4 months from July to October in 2015.

resultsOf the 85 approached pharmacists, 66 pharmacists completed the questionnaire, among which 45 (68.2%), 9 (13.6%), and 12 (18.2%) of them were outpatient hospital pharmacists, discharge counselling pharmacists, and pharmacy practice residents, respectively. In total, 47 (55.3%) of the pharmacists sought drug information resources for newly prescribed medications to hemodialysis patients. Among the surveyed pharmacists, around two-thirds of them (63.6%) were completely confident during counselling hemodialysis patients, while 32% were moderately confident, and only 4.5% were not confident. All of the participating pharmacists checked each patient's allergic status before dispensing hemodialysis medications. The majority of the outpatient hospital pharmacists (35; 77.8%), discharge pharmacists (8; 88.9%), and the pharmacy practice residents (11; 91.7%) agreed that oral ciprofloxacin should be given after dialysis session on the same dialysis days, while 18 (40%), 5 (55.6%), and 9 (75%) of the outpatient hospital pharmacists, discharge pharmacists, and pharmacy practice residents agreed that IV route is preferred for hemodialysis patients to administer epoetin alfa, respectively. Sixty-six percent of discharge pharmacists (

conclusionsDespite the limited knowledge regarding some prescribed medications, most of the hospital pharmacists showed good practices toward dialysis patients.

Indexed as

attitudeCRFdialysishospital pharmacistsknowledge

Identifiers

PMID34574871
PMCPMC8468859
OpenAlexW3195468517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.